Long-term nintedanib treatment in idiopathic pulmonary fibrosis (IPF): new data from INPULSIS-ON

B. Crestani (Paris, France)

Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights
Session: Idiopathic pulmonary fibrosis (IPF): treatment highlights
Session type: Oral Presentation
Number: 3402
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Crestani (Paris, France). Long-term nintedanib treatment in idiopathic pulmonary fibrosis (IPF): new data from INPULSIS-ON. 3402

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: